Navigation Links
Newer antimalarials more effective than quinine against severe malaria
Date:3/15/2011

Quinine should no longer be the drug of choice for treating severe malaria, according to an updated systematic review by Cochrane researchers. It is now evident that the antimalarial drug artesunate, which is derived from herbs used in Chinese medicine, is more effective at preventing death in patients with severe malaria.

Severe malaria occurs when the disease affects the function of vital organs. It is associated with rarer cerebral malaria, which affects the brain and can lead to long-term disability. More than a million people die each year from severe malaria, the majority in Sub-Saharan Africa. Artesunate was recommended as the preferred treatment for adults with severe malaria by the World Health Organization (WHO) in 2006, but there was insufficient evidence at the time to recommend a change from the standard treatment of quinine in children.

The researchers updated the review of artesunate by adding a new large multicentre trial of African children published in the Lancet in 2010 to the existing 8 trials. The review now includes a total of 1664 adults and 5765 children, from a variety of settings across Africa and Asia. According to the results, taking artesunate reduces the risk of death by 39% in adults and 24% in children compared to quinine. In adults, deaths caused by severe malaria were reduced from 241 per 1000 with quinine to 147 with artesunate. In children, deaths were reduced from 108 per 1000 with quinine to 83 with artesunate.

"There is now enough evidence to be confident of these results in adults and children," said Peter Olumese of the WHO's Global Malaria Programme. "Intravenous artesunate is now being recommended as the treatment of choice for adults and children with severe malaria anywhere in the world."

Although more children given artesunate suffered neurological problems compared to those given quinine, these were largely resolved within a month of treatment, and were outweighed by the increase in survival rates. "The balance of benefits and harms is in favour of treatment with artesunate," said David Sinclair of the Liverpool School of Tropical Medicine in Liverpool, UK, who led the review team.


'/>"/>

Contact: Jennifer Beal
healthnews@wiley.com
44-012-437-70633
Wiley-Blackwell
Source:Eurekalert

Related medicine news :

1. Research shows rapid adoption of newer, more expensive prostate cancer treatments
2. Newer Drug May Help Prevent Fracture in Men With Prostate Cancer
3. Newer, more intense chemotherapy with less radiation not more effective against Hodgkins lymphoma
4. Decrease in suicide not linked to newer antidepressants
5. Newer Drugs Beat Gleevec in Head-to-Head Trials
6. In infant heart surgery, newer technique yields better survival in first year of life
7. Newer Genetic Info Adds Little to Predicting Breast Cancer
8. Newer Blood Thinner Beats Plavix for Bypass Patients
9. Newer Genetic Test for Autism More Effective
10. Newer Blood Test Predicts Diabetes, Heart Disease
11. Newer cornea transplant surgery shows short- and long-term promise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... (PRWEB) , ... January 16, 2017 , ... St. Louisans are well-aware of the following ... This year’s influenza shot seems to be having no effect on keeping this ... least half of the people around are coughing, sneezing, or sniffling , ...
(Date:1/16/2017)... (PRWEB) , ... January 16, 2017 , ... ... in the Aesthetic Surgery Journal , the official journal of The American ... on lower eyelid retraction surgery. The procedure is designed to correct drooping, retracted ...
(Date:1/16/2017)... CITY, UT (PRWEB) , ... January 16, 2017 , ... ... disease not only to treat, but to test for, as well. The money spent ... billion every year.(1) Doctors in the U.S. screen patients for cancer more than in ...
(Date:1/16/2017)... ... January 16, 2017 , ... Vixiar Medical, ... of the medical device company, effective immediately. , “This is perfect timing for ... a strong track record in medical device market development and revenue growth, particularly ...
(Date:1/15/2017)... ... 15, 2017 , ... In this role, Courtney will be responsible for developing ... & allergy friendly mark. This certification program was created by ASL and the nonprofit ... be more suitable for the 60+ million people living in the U.S. with asthma ...
Breaking Medicine News(10 mins):
(Date:1/16/2017)... , Jan. 16, 2017 ... Market Outlook to 2022", provides key market data on ... value, in millions of US dollars, volume (in units) ... Energy X-Ray Absorptiometry (DEXA) and Quantitative Ultrasound (QUS). ... data for each of these market segements, and global ...
(Date:1/16/2017)... , Jan. 16, 2017 Infusion ... devices used for administering medications in a controlled, ... used for therapeutic purposes in critical care, pain ... required to make patient,s feel comfortable and pain ... errors which would lead to serious life threatening ...
(Date:1/16/2017)... BOTHELL, Wash. , Jan. 16, 2017  Verathon ® ... devices, announced the launch of new GlideScope ® Spectrum TM ... all-new Dynamic Light Control TM and Ambient Light Reduction TM ... Continue Reading ... ...
Breaking Medicine Technology: